You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Interleukin 33 (IL33) Antibodies

IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4; MIM 147780). Additionally we are shipping Interleukin 33 Proteins (107) and Interleukin 33 Kits (59) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
IL33 90865 O95760
IL33 77125 Q8BVZ5
IL33 361749 Q66H70
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Interleukin 33 Antibodies at antibodies-online.com

Showing 10 out of 371 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IHC, WB WB Suggested Anti-IL33 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:62500Positive Control: 293T cell lysate 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Mouse Un-conjugated EIA, WB 0.1 mL Log in to see 6 to 8 Days
$412.50
Details
Human Rabbit Biotin ELISA, WB Western blot using anti-Human IL-33 antibody shows detection of a band ~18 kDa in size corresponding to recom-binant human IL-33 (lane 1). The identity of the higher molecular weight band is unknown. Molecular weight markers are also shown (M). After transfer, the membrane was blocked overnight with 3% BSA in TBS followed by reaction with primary antibody at a 1:1,000 dilution. Detection occurred using peroxidase conjugated anti-Rabbit IgG (p/n 611-103-122) secondary antibody diluted 1:40,000 in blocking buffer (p/n MB-070) for 30 min at RT followed by reaction with FemtoMax™ chemiluminescent substrate. Image was captured using VersaDoc™ MP 4000 imaging system (Bio-Rad). 100 μg Log in to see 2 to 3 Days
$379.00
Details
Human Rabbit HRP EIA, WB 0.1 mg Log in to see 6 to 8 Days
$500.50
Details
Human Mouse Un-conjugated Func, IP, IHC, ELISA, WB Inhibition of binding of recombinant human IL-33 (hIL-33) to human ST2 (hST2) in vitro using anti-IL-33 (human), mAb (IL33305B) . An indirect competitive ELISA was performed as follows; 1) coat microtiter plate wells with hST2-Fc (10 ug/ml); 2) add 2 ug/ml of IL-33 with or without a hIL-33 mAb to the wells followed by washing; 3) add anti-FLAG HRP conjugated (1:2,000) to an enzyme; 4) after adding the TMB solution, incubate at RT in the dark for 20 minutes. Immediately read the plate at 450 nm. Western blot analysis of human IL-33 using anti-IL-33 (human), mAb (IL33305B)  at 1:2,000 dilution. 1). Recombinant human IL-33 (His tagged). 2). Recombinant human IL-33 (FLAG ® -tagged). 3). Recombinant mouse IL-33 (FLAG ® -tagged). 4). Other protein (His tagged, negative control). 100 μg Log in to see 5 to 8 Days
$351.75
Details
Human Rabbit Un-conjugated EIA, IF, WB Immunofluorescence of IL-33 in human lymph node tissue with AP30426PU-N IL-33 antibody at 20 μg/ml. Western blot analysis of IL-33 in human lymph node tissue lysate with AP30426PU-N IL-33 antibody at (A) 1 and (B) 2 μg/ml. 0.1 mg Log in to see 6 to 8 Days
$401.50
Details
Human Rabbit Un-conjugated EIA, WB Western blot analysis of IL-33 in human lymph node tissue lysate with AP30427PU-N IL-33 antibody at (A) 1 and (B) 2 μg/ml. 0.1 mg Log in to see 6 to 8 Days
$401.50
Details
Mouse Goat Biotin FACS 50 μg Log in to see 10 to 12 Days
$244.59
Details
Human Goat Biotin FACS 50 μg Log in to see 10 to 12 Days
$244.59
Details
Human Rat PE FACS Detection of IL-33 in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Rat Anti-Human IL-33 PE-conjugated Monoclonal Antibody. 100 Tests Log in to see 6 to 7 Days
$393.75
Details

IL33 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, , , ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) , , , ,
, , , , , ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , , ,
, ,
,
, , , , , , , , , , ,

Top referenced anti-Interleukin 33 Antibodies

  1. Mouse (Murine) Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661329 : Arend, Palmer, Gabay: IL-1, IL-18, and IL-33 families of cytokines. in Immunological reviews 2008 (PubMed)
    Show all 5 references for ABIN2661329

  2. Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN500014 : Dinarello: Interleukin-18, a proinflammatory cytokine. in European cytokine network 2000 (PubMed)
    Show all 4 references for ABIN500014

  3. Human Polyclonal Interleukin 33 Primary Antibody for EIA, IF - ABIN500012 : Brint, Xu, Liu, Dunne, McKenzie, ONeill, Liew: ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. in Nature immunology 2004 (PubMed)
    Show all 4 references for ABIN500012

  4. Human Monoclonal Interleukin 33 Primary Antibody for Func, IP - ABIN1169172 : Pace, Di Sano, Sciarrino, Scafidi, Ferraro, Chiappara, Siena, Gangemi, Vitulo, Giarratano, Gjomarkaj: Cigarette smoke alters IL-33 expression and release in airway epithelial cells. in Biochimica et biophysica acta 2014 (PubMed)
    Show all 4 references for ABIN1169172

  5. Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN401104 : Hayakawa, Hayakawa, Matsuyama, Tamemoto, Okazaki, Tominaga: Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. in Biochemical and biophysical research communications 2009 (PubMed)
    Show all 4 references for ABIN401104

  6. Human Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661328 : McLaren, Michael, Salter, Ashlin, Calder, Miller, Liew, Ramji: IL-33 reduces macrophage foam cell formation. in Journal of immunology (Baltimore, Md. : 1950) 2010 (PubMed)
    Show all 3 references for ABIN2661328

  7. Human Monoclonal Interleukin 33 Primary Antibody for FACS - ABIN4895753 : Tada, Matsuyama, Nishioka, Hagiwara, Kiyoura, Shimauchi, Matsushita: Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells. in PLoS ONE 2016 (PubMed)

  8. Human Polyclonal Interleukin 33 Primary Antibody for IHC, WB - ABIN2784443 : Humphreys, Xu, Hepworth, Liew, Grencis: IL-33, a potent inducer of adaptive immunity to intestinal nematodes. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)

  9. Human Monoclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN317536 : Baekkevold, Roussigné, Yamanaka, Johansen, Jahnsen, Amalric, Brandtzaeg, Erard, Haraldsen, Girard: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. in The American journal of pathology 2003 (PubMed)

More Antibodies against Interleukin 33 Interaction Partners

Human Interleukin 33 (IL33) interaction partners

  1. This study suggests a possible systemic role of IL-33 in the pathogenesis of vitiligo (show MITF Antibodies).

  2. IL-33 expression may serve as an independent negative predictor of survival for patients with clear-cell renal cell carcinoma (show MOK Antibodies) after surgery.

  3. Serum upregulated IL-33 could contribute to the pathogenesis of chronic allograft dysfunction in kidney transplant recipients.

  4. No significant differences in genotypic and allelic frequencies of the rs3939286 in interleukin 33 was observed between cases and controls and between mild/severe and early/late-onset Preeclampsia.

  5. Reduced IL-33 levels and rs16924159 IL-33 variant may contribute to the pathogenesis of idiopathic recurrent miscarriage in Chinese Han population.

  6. In a CML (show BCR Antibodies) patient with pruritus receiving imatinib mesylate, IL-31 (show IL31 Antibodies) and IL-33 serum levels were significantly higher than controls. Imatinib could cause keratinocyte injury, the release of IL-33, and the consequent interaction with its receptor on mast cells, inducing IL-31 (show IL31 Antibodies) secretion. The IL-31 (show IL31 Antibodies)/IL-33 axis may be involved in the pathogenesis of skin side effects related to imatinib mesylate treatment.

  7. IL-33 and ST2 are expressed in periapical granulomas and radicular cysts.

  8. in breast tumors from 40 female patients with absent or present tumor necrosis there was significantly higher expression of IL-33, IL-33R and VEGF in breast cancer tissues with absent tumor necrosis. Both, IL-33 and IL-33R expression correlated with VEGF expression in tumor cells.

  9. Data suggest that interleukin 33 (IL-33) may play an important role in the development of non-small cell lung cancer (NSCLC) and the targeted therapy.

  10. rs7044343 polymorphism of IL-33 gene is associated with the susceptibility to systemic sclerosis in Turkish population.

Mouse (Murine) Interleukin 33 (IL33) interaction partners

  1. anti-allergic effect of anti-IL-33 antibodies associated with suppression of immunoglobulin free light chain and nitric oxide synthase (show NOS Antibodies) in a murine model of allergic rhinitis

  2. Data suggest that IL-33 and ST2 function as a developmental switch to license thermogenesis during the perinatal period.

  3. some SNPs of ST2-IL18R1-IL18RAP gene cluster might increase the risk of susceptibility of Graves' disease (GD) and Hashimoto's thyroiditis (HT) in Chinese Han population.

  4. Furthermore, IL-33 injection modulates the innate immune response by polarizing microglia/macrophages toward an antiinflammatory phenotype and reducing the expression of proinflammatory genes, including IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies), and NLRP3 (show NLRP3 Antibodies), in the cortices of APP (show APP Antibodies)/PS1 (show PSEN1 Antibodies) mice. Collectively, our results demonstrate a potential therapeutic role for IL-33 in AD.

  5. absence of IL-33 has no negative consequences in normal bone homeostasis while high levels of circulating IL-33 contributes to pathological bone loss.

  6. pre-treatment with the ERK1/2 (show MAPK1/3 Antibodies) inhibitor U0126 or anti-IL-33 antibody significantly abolished the ovalbumin (show OVA Antibodies)-induced airway remodeling, increased expressions of IL-33

  7. IL-33 promotes degranulation of bone marrow-derived mast cells and release of cytokines IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies) and TNF-alpha (show TNF Antibodies).

  8. pulmonary interstitial macrophages may not be a source of IL-33 during Respiratory syncytial virus infection

  9. demonstrate a pathogenic role for IL-33-mediated eosinophilia and activation of Th2 immunity in chronic intestinal inflammation

  10. IL-33 as a novel regulator of neutrophil function in antibacterial infection

Pig (Porcine) Interleukin 33 (IL33) interaction partners

  1. IL-33 may be a key molecule operating in eosinophil-mediated fibrosis in high-dose-per fraction irradiated skin.

Interleukin 33 (IL33) Antigen Profile

Protein Summary

IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4\; MIM 147780). IL33 is a ligand for IL33R (IL1RL1\; MIM 601203), an IL1 family receptor that is selectively expressed on Th2 cells and mast cells (summary by Yagami et al., 2010

Gene names and symbols associated with anti-Interleukin 33 (IL33) Antibodies

  • interleukin 33 (IL33) antibody
  • interleukin 33 (Il33) antibody
  • interleukin 33-like (LOC100356081) antibody
  • interleukin-33-like (LOC100518643) antibody
  • 9230117N10Rik antibody
  • C9orf26 antibody
  • DVS27 antibody
  • Il-33 antibody
  • Il1f11 antibody
  • IL33 antibody
  • NF-HEV antibody
  • NFEHEV antibody
  • RGD1311155 antibody
  • RP11-575C20.2 antibody

Protein level used designations for anti-Interleukin 33 (IL33) Antibodies

interleukin 33 , IL-33 , interleukin-33 , DVS27-related protein , IL-1F11 , interleukin-1 family member 11 , nuclear factor for high endothelial venules , nuclear factor from high endothelial venules

GENE ID SPECIES
737537 Pan troglodytes
100171950 Pongo abelii
90865 Homo sapiens
77125 Mus musculus
361749 Rattus norvegicus
100715993 Cavia porcellus
403810 Canis lupus familiaris
507054 Bos taurus
101116705 Ovis aries
100356081 Oryctolagus cuniculus
100518643 Sus scrofa
Selected quality suppliers for anti-Interleukin 33 (IL33) Antibodies
Did you look for something else?